For a complete listing of publications click here.
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, and Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988;242: 1528-1534.
Wolfman NM, Hattersley G, Celeste AJ, Nelson R, Yamaji N, Dube JL, DiBlasio-Smith E, Nove J, Song JJ, Wozney JM, and Rosen V. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-b gene family. J Clin Investig 1997; 100: 1-10.
Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM. The type I BMPRIB is required for chondrogenesis in the mouse limb. Development 2000; 127(3):621-30.
Dailuski A, Engstrand T, Bahamonde M, Tompkinson K, Gamer LW, Rosen V, and Lyons KM. BMP3 is a negative regulator of bone density. Nature Genet 2001; 27: 84-88.
Gamer LW, Cox KA, Small C, and Rosen V. Gdf11 is a negative regulator of chondrogenesis and myogensis in the developing chick limb. Dev Biol 2001; 229: 407-420.
Tsuji K, Bandyopadhyay A, Harfe BD, Cox KA, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, and Rosen, V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet. 2006; 38: 1424-1429.
Gamer LW, Tsuji K, Cox K, Capelo LP, Lowery J, Beppu H, Rosen V. BMPR-II is dispensible for formation of the limb skeleton. Genesis 2011; May 2
Pazin DE, Gamer LW, Cox KA and Rosen V. Molecular profiling of synovial joints: use of microarray analysis to identify factors that direct development of the knee and elbow. Dev Dyn 2012, 241: 1861-26.
Pazin DE, Gamer LW, Capelo LP, Cox KA and Rosen V. Gene signature of the embryonic meniscus. J Orthop Res 2014, 32: 46-53.
Lowery JW, Intini G, Gamer L, Lotinun S, Salazar VS, Ote S, Cox K, Baron R, Rosen V. Loss of BMPR2 leads to high bone mass due to increased osteoblast activity. J Cell Sci. 2015 Apr 1;128(7):1308-15.
Muhammad H, Schminke B, Bode C, Roth M, Albert J, von der Heyde S, Rosen V, Miosge N. Human migratory meniscus progenitor cells are controlled via the TGF-β pathway. Stem Cell Reports. 2014 Nov 11;3(5):789-803.